Basilea Pharmaceutica AG (SWX:BSLN)
51.60
+0.40 (0.78%)
At close: Dec 5, 2025
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 634.04 million as of December 5, 2025. Its market cap has increased by 31.59% in one year.
Market Cap
634.04M
Enterprise Value
602.46M
Revenue
236.21M
Ranking
n/a
PE Ratio
9.43
Stock Price
51.60
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 634.04M, an increase of 18.89%. That is a compound annual growth rate of 0.80%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 266.08B |
| Novartis AG | 205.46B |
| Galderma Group AG | 38.65B |
| Lonza Group AG | 38.51B |
| Alcon | 32.12B |
| Sandoz Group AG | 24.56B |
| Straumann Holding AG | 14.62B |
| Sonova Holding AG | 12.06B |